Lori McPartlin is a strategic CMC program leader with extensive experience in biopharmaceutical and life sciences. They have held positions ranging from Product Development Research Associate II at Organogenesis, Inc. to Senior Manager of CMC Operations at TScan Therapeutics, where they guide multiple clinical programs and oversee technology transfer and compliance with regulatory strategies. Lori earned a PhD in Molecular and Integrative Physiology from Cornell University and has contributed significantly to the fields of regenerative medicine and cell therapy, demonstrating expertise across various stages of product development.
This person is not in any teams
This person is not in any offices